Nanocarriers for Skin Applications: Where Do We Stand?

  • Tiwari N
  • Osorio‐Blanco E
  • Sonzogni A
  • et al.
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Skin penetration of active molecules for treatment of diverse diseases is a major field of research owing to the advantages associated with the skin like easy accessibility, reduced systemic‐derived side effects, and increased therapeutic efficacy. Despite these advantages, dermal drug delivery is generally challenging due to the low skin permeability of therapeutics. Although various methods have been developed to improve skin penetration and permeation of therapeutics, they are usually aggressive and could lead to irreversible damage to the stratum corneum. Nanosized carrier systems represent an alternative approach for current technologies, with minimal damage to the natural barrier function of skin. In this Review, the use of nanoparticles to deliver drug molecules, genetic material, and vaccines into the skin is discussed. In addition, nanotoxicology studies and the recent clinical development of nanoparticles are highlighted to shed light on their potential to undergo market translation.

Cite

CITATION STYLE

APA

Tiwari, N., Osorio‐Blanco, E. R., Sonzogni, A., Esporrín‐Ubieto, D., Wang, H., & Calderón, M. (2022). Nanocarriers for Skin Applications: Where Do We Stand? Angewandte Chemie, 134(3). https://doi.org/10.1002/ange.202107960

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free